Shandong Xinhua Pharmaceutical Co Ltd (000756) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of CN¥56.11 Million could theoretically repay 0% of its total liabilities (CN¥3.22 Billion) in one year. See Shandong Xinhua Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Co Ltd. Check Shandong Xinhua Pharmaceutical Co Ltd (000756) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥367.61 Million | CN¥3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | CN¥265.28 Million | CN¥3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | CN¥758.24 Million | CN¥3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | CN¥259.12 Million | CN¥3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | CN¥420.19 Million | CN¥3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | CN¥348.27 Million | CN¥3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | CN¥323.91 Million | CN¥3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | CN¥389.97 Million | CN¥2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | CN¥439.35 Million | CN¥2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | CN¥348.64 Million | CN¥2.51 Billion | — |